Hemostatic Soft Tissue Adhesives

Summary of the technology

Novel bio-adhesives based on the natural polymers, gelatin (protein) and alginate (polysaccharide), and a carbodiimide crosslinking agent. The carbodiimide crosslinking agent is much less toxic than other crosslinking agents used in bioadhesives and therefore our bioadhesives exhibit enhanced biocompatibility. Our bioadhesives provide rapid adhesion, maintain a strong and close apposition of wound edges (to allow for natural wound healing), do not interfere with the body’s natural healing mechanisms and degrade without producing any inflammatory response. In addition, they are viscous liquids before curing, allowing for easy application, and solidify quickly with a low gelation time.
Project ID : 2-2011-275

RAMOT at Tel Aviv University Ltd.

Details of the Technology Offer

Novel bio-adhesives based on the natural polymers, gelatin (protein) and alginate (polysaccharide), and a carbodiimide crosslinking agent. The carbodiimide crosslinking agent is much less toxic than other crosslinking agents used in bioadhesives and therefore our bioadhesives exhibit enhanced biocompatibility. Our bioadhesives provide rapid adhesion, maintain a strong and close apposition of wound edges (to allow for natural wound healing), do not interfere with the body’s natural healing mechanisms and degrade without producing any inflammatory response. In addition, they are viscous liquids before curing, allowing for easy application, and solidify quickly with a low gelation time.

The Need
Tissue adhesives are substances that hold tissues together, and are broadly applicable in medicine and surgery. In appropriate circumstances, they are even preferred alternatives to sutures and staples since they can be applied more quickly, cause less pain and require less equipment. In addition to their use in topical wound closure they can supplement or replace sutures or staples in internal surgical procedures. Soft tissue adhesives can also be used for bleeding control, as sealants preventing air leakage from the lungs, and in repairing aortic dissections and external fixation of certain devices.

Advantages

  • Superior adhesion strength, ease of handling and biocompatibility.
  • Possibility of incorporating hemostatic agents, enabling bleeding control.
  • Design enables integration and release of drugs (antibiotics and pain killers) in a controlled desired manner.

Current market of surgical adhesives includes cyanoacrylates, fibrin sealants and protein-based bioadhesives. These products do not combine the aforementioned capabilities. Cyanoacrylates are toxic, carcinogenic and exhibit over stiffness, while fibrin sealants exhibit poor tissue adhesion and risk of transferring diseases.

Project Status
We have excellent in-vitro (bonding strength, biocompatibility, gelation time etc.) and excellent in-vivo results.

Patents and Status
A patent in PCT stage.

Supporting Publications
 Gelatin-Alginate Novel Tissue Adhesives and their Formulation-Strength Effects: B Cohen, O Pinkas, M Foox and M Zilberman, Acta Biomaterialia, 9, 9004-9011 (2013).
 Effect of Bioactive Fillers on the Structure and Bonding Strength of Novel Gelatin-Alginate Bioadhesives: B Cohen, M Panker, E Zuckerman, M Foox and M Zilberman, Journal of Biomaterials Applications, in press.
 Novel Gelatin-Alginate Soft Tissue Adhesives Loaded with Drugs for Pain Management: Structure and Properties B Cohen, A Shefy-Peleg and M Zilberman, Journal of Biomaterials Science – Polymer edition, in press.
 Antibiotic Eluting Gelatin-Alginate Novel Soft Tissue Adhesives A Shefy-Peleg, M Foox, B Cohen and M Zilberman, International Journal of Polymeric Materials and Polymeric Biomaterials, in press.

Project manager

Rona Samler
VP, BD Physical Science, Medical Device, Chemistry

Project researchers

Meital Zilberman
T.A.U Tel Aviv University, Engineering
Bio-Medical Engineering

Related Keywords

  • Other Energy Topics
  • Chemistry
  • Medicine, Human Health
  • Diagnostics, Diagnosis
  • Medical Technology / Biomedical Engineering
  • Biology / Biotechnology
  • Cellular and Molecular Biology Technology
  • Microbiology Technology
  • Bioinformatics Technology
  • Micro- and Nanotechnology related to Biological sciences
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Bioinformatics Market
  • Diagnostic
  • Medical imaging
  • Therapeutic
  • Other Medical/Health Related
  • Other medical/health related (not elsewhere classified)
  • Medical equipment
  • Other Energy
  • medical devices
  • Therapeutic Instruments
  • Pharmaceutical Indications
  • dermatology
  • Life Sciences and Biotechnology
  • polymers
  • Life Sciences and Biotechnology
  • Natural Compounds

About RAMOT at Tel Aviv University Ltd.

Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.

RAMOT at Tel Aviv University Ltd.

Never miss an update from RAMOT at Tel Aviv University Ltd.

Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide

RAMOT at Tel Aviv University Ltd.

Send a request for information
to RAMOT at Tel Aviv University Ltd.

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support